Ampersand-backed Alliance Pharma to buy LGC's DDS
Alliance Pharma, which is backed by Ampersand Capital Partners, has agreed to acquire UK-based LGC's Drug Development Solutions business.
17 May 2022•3 mins read
Alliance Pharma, which is backed by Ampersand Capital Partners, has agreed to acquire UK-based LGC's Drug Development Solutions business.
Walter Capital Partners takes significant stake in Quebec educational games maker Passe-Temps
11 hours ago · 1 min read
Truelink Capital’s GES buys CSG Creative from National Trade Productions
11 hours ago · 2 mins read
MPE Partners’ Intermatic adds outdoor lighting-control products maker Sun-Tech
11 hours ago · 2 mins read
Velocity Capital Management backs founder Griffin Haddrill with stake in LV8, Mirage
12 hours ago · 1 min read
Aterian’s Outlook Group completes acquisition of Graham-backed ABX’s Pewaukee packaging facility
12 hours ago · 1 min read
FPE Capital’s NoBlue2 adds PeopleWalking’s Spanish NetSuite business in Europe push
12 hours ago · 1 min read
PE targets identity security as AI transforms threats: 6 deals
14 hours ago · 3 mins read
